Shiraki K - Search Results

1

Yucca leaf protein (YLP) stops the protein synthesis in HSV-infected cells and inhibits virus replication.

Hayashi K, Nishino H, Niwayama S, Shiraki K, Hiramatsu A. Hayashi K, et al. Among authors: shiraki k. Antiviral Res. 1992 Apr;17(4):323-33. doi: 10.1016/0166-3542(92)90027-3. Antiviral Res. 1992. PMID: 1322646

2

Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.

Shiraki K, Ochiai H, Namazue J, Okuno T, Ogino S, Hayashi K, Yamanishi K, Takahashi M. Shiraki K, et al. Antiviral Res. 1992 Jun;18(2):209-14. doi: 10.1016/0166-3542(92)90039-8. Antiviral Res. 1992. PMID: 1329651

3

Effect of FK-506 on replication of human cytomegalovirus in vitro.

Shiraki K, Ishibashi M, Okuno T, Hayashi K, Yamanishi K, Takahashi M, Ogino S, Sonoda T. Shiraki K, et al. J Antibiot (Tokyo). 1991 May;44(5):550-2. doi: 10.7164/antibiotics.44.550. J Antibiot (Tokyo). 1991. PMID: 1712008 Free article. No abstract available.

4

Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro.

Shiraki K, Ishibashi M, Okuno T, Namazue J, Yamanishi K, Sonoda T, Takahashi M. Shiraki K, et al. Arch Virol. 1991;117(3-4):165-71. doi: 10.1007/BF01310762. Arch Virol. 1991. PMID: 1850228

5

Phosphonoacetic acid inhibits replication of human herpesvirus-6.

Shiraki K, Okuno T, Yamanishi K, Takahashi M. Shiraki K, et al. Antiviral Res. 1989 Dec;12(5-6):311-8. doi: 10.1016/0166-3542(89)90058-2. Antiviral Res. 1989. PMID: 2561336

6

Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).

Shiraki K, Miyaki C, Namazue J, Yamanishi K, Takahashi M. Shiraki K, et al. Acta Virol. 1989 Dec;33(6):565-8. Acta Virol. 1989. PMID: 2576598

7

Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice.

Kurokawa M, Ochiai H, Nagasaka K, Neki M, Xu H, Kadota S, Sutardjo S, Matsumoto T, Namba T, Shiraki K. Kurokawa M, et al. Among authors: shiraki k. Antiviral Res. 1993 Oct;22(2-3):175-88. doi: 10.1016/0166-3542(93)90094-y. Antiviral Res. 1993. PMID: 8279811

8

Isolation and structure of woodorien, a new glucoside having antiviral activity, from Woodwardia orientalis.

Xu HX, Kadota S, Kurokawa M, Shiraki K, Matsumoto T, Namba T. Xu HX, et al. Among authors: shiraki k. Chem Pharm Bull (Tokyo). 1993 Oct;41(10):1803-6. doi: 10.1248/cpb.41.1803. Chem Pharm Bull (Tokyo). 1993. PMID: 8281578

9

Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.

Hasegawa T, Kurokawa M, Yukawa TA, Horii M, Shiraki K. Hasegawa T, et al. Among authors: shiraki k. Antiviral Res. 1995 Jun;27(3):271-9. doi: 10.1016/0166-3542(95)00007-9. Antiviral Res. 1995. PMID: 8540749

10

Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon).

Yamamura J, Koyasu M, Sato H, Kurokawa M, Yoshida Y, Amahabu Y, Shiraki K. Yamamura J, et al. Among authors: shiraki k. J Dermatol Sci. 1996 Apr;12(1):50-5. doi: 10.1016/0923-1811(95)00464-5. J Dermatol Sci. 1996. PMID: 8740461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,023 results

Search Page

Filters